Coronary heart disease 1

Common Name(s)

Coronary heart disease 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Coronary heart disease 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Coronary heart disease 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Coronary heart disease 1" returned 60 free, full-text research articles on human participants. First 3 results:

C-reactive Protein Level, Apolipoprotein B-to-apolipoprotein A-1 Ratio, and Risks of Ischemic Stroke and Coronary Heart Disease among Inner Mongolians in China.
 

Author(s): Yun Fan Tian, Yi Peng Zhou, Chong Ke Zhong, Batu Buren, Tian Xu, Hong Mei Li, Ming Zhi Zhang, Ai Li Wang, Yong Hong Zhang

Journal: Biomed. Environ. Sci.. 2016 Jul;29(7):467-74.

 

We aimed to investigate the cumulative effect of high CRP level and apolipoprotein B-to-apolipoprotein A-1 (ApoB/ApoA-1) ratio on the incidence of ischemic stroke (IS) or coronary heart disease (CHD) in a Mongolian population in China.

Last Updated: 24 Aug 2016

Go To URL
Association between matrix metallopeptidase 1 and type 2 diabetes mellitus coexisting with coronary heart disease in a Han Chinese population.
 

Author(s): Y Z Ma, Q Y Jiang, D Q Kong

Journal:

 

Matrix metallopeptidase 1 (MMP-1) has been reported to be involved in the coexistence of type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD). We sought to examine the association between the MMP-1 gene polymorphism and coexistence of T2DM and CHD in a Han Chinese population. ...

Last Updated: 21 Jun 2016

Go To URL
Analysis of correlations between coronary heart disease and haplotypes of the angiotensin II receptor type 1 (AGTR1) gene.
 

Author(s): L J Duan, X D Wang

Journal:

 

This study aimed to explore correlations between haplotypes of the angiotensin II receptor type 1 (AGTR1) gene and coronary heart disease (CHD). In total, 204 patients with CHD and 206 healthy controls were genotyped using denaturing high-performance liquid chromatography between ...

Last Updated: 7 Apr 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Coronary heart disease 1" returned 3 free, full-text review articles on human participants. First 3 results:

The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participants.
 

Author(s): Morgana L Mongraw-Chaffin, Sanne A E Peters, Rachel R Huxley, Mark Woodward

Journal: Lancet Diabetes Endocrinol. 2015 Jun;3(6):437-49.

 

The risk of developing coronary heart disease differs by sex, and accumulating evidence suggests that sex differences exist in the effect of coronary risk factors on vascular risk. So far, the existence of a sex difference in the association between BMI and coronary heart disease ...

Last Updated: 25 May 2015

Go To URL
The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy.
 

Author(s): Howard N Hodis, Wendy J Mack

Journal: J Am Geriatr Soc. 2013 Jun;61(6):1005-10.

 

The long-held belief that outcome data from intervention trials in men are generalizable to women has created the framework in which the primary prevention of coronary heart disease (CHD) in women is viewed, but over the past decade, data have accumulated to refute such a supposition ...

Last Updated: 18 Jun 2013

Go To URL
Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review.
 

Author(s): M Duong, M Buisson, Y Cottin, L Piroth, I Lhuillier, M Grappin, P Chavanet, J E Wolff, H Portier

Journal: Clin Cardiol. 2001 Oct;24(10):690-4.

 

Four cases of human immunodeficiency virus (HIV)-infected patients who developed coronary heart disease (CHD) while under treatment with a protease inhibitor (PI) are described, and the epidemiologic and clinical features of 18 cases reported in the literature are analyzed. Cardiac ...

Last Updated: 11 Oct 2001

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?
 

Status: Recruiting

Condition Summary: Coronary Artery Disease

 

Last Updated: 8 May 2016

Go to URL
Dynamic Changes in SDF-1α Levels in Acute and Stabilized Heart Disease
 

Status: Recruiting

Condition Summary: Atrial Fibrillation; Ischemic Heart Disease; Congestive Heart Failure

 

Last Updated: 3 Aug 2016

Go to URL